ArticleJCO precision oncology2023

Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel

Katharine Offer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.